APOE and Parkinson disease: ANCOVA models then revealed that PD APOE4 carriers had significantly lower GMV in the left nucleus accumbens (NAcc) when adjusting for age, sex, disease duration, and TIV compared to non-carriers (F1,165 = 6.034, p = 0.015) (Fig 2, S4 Table).